GVFL (Gujarat Venture Finance Limited) is one of India's oldest venture capital institutions. Founded in 1990 at the World Bank's initiative and headquartered in Ahmedabad, the fund manager has raised nine funds supporting more than 110 companies. Its thesis: partner selectively with highly scalable, innovative, technology-enabled businesses run by credible teams — and go beyond capital with strategic direction, governance, mentoring and acceleration support across the startup lifecycle.
Investment thesis
GVFL's edge is patience and domain depth in hard-tech sectors that newer funds often avoid. The firm has built a reputation in biotechnology and deep tech alongside enterprise tech — sectors where diligence takes longer and payoffs arrive later, but where India's research institutions produce genuine IP. Its stated commitment goes beyond the cheque: strategic direction, governance discipline and lifecycle mentoring.
Funds, sectors, stages and cheque sizes
GVFL invests from pre-seed to Series B across biotechnology, deep tech, enterprise tech, clean tech, defence tech, healthcare and med-tech, consumer brands, gaming and entertainment, fintech and agri tech. Ticket sizes are published per fund: the iCreate Angel Fund writes Rs 25 lakh–1.5 crore for pre-seed Gujarat startups, the Prarambh Fund writes Rs 50 lakh–3 crore at seed stage, and the Emerging Enterprise Venture Fund writes Rs 5–20 crore. The Prarambh Fund achieved a first close of Rs 100 crore towards a Rs 200 crore target in 2024. Aggregate AUM is not publicly disclosed.
Notable portfolio
Names in the portfolio include Amrita Therapeutics, Axio Biosolutions, Canvaloop, Magma, QRL Bioscience and Varmora Homeware.
People
The firm is led by Managing Directors Kamal Bansal, Mihir Joshi and Sanjay Randhar.
Programs and founder support
GVFL runs a multi-sector startup accelerator with Brinc, maintains partnerships with Ahmedabad University and GUSEC, and publishes a Coffee Table Book of top Gujarat startups. No formal credits or perks programme is publicly documented.
How to engage
GVFL's three funds are three doors: Gujarat pre-seed founders enter through the iCreate Angel Fund (Rs 25 lakh–1.5 crore), seed-stage companies through the Prarambh Fund (Rs 50 lakh–3 crore), and scaling companies through the Emerging Enterprise Venture Fund (Rs 5–20 crore). Deep-tech and biotech founders should lead with the science — IP position, research pedigree and regulatory pathway — because this is a firm that has underwritten R&D risk since 1990. The Brinc accelerator partnership and university linkages also offer non-capital entry points into the firm's orbit.
Why it matters for founders
Deep-tech and biotech founders outside the metro VC circuit should know GVFL by name — it has underwritten science-led businesses for three decades and understands regulatory and R&D timelines that generalist funds find uncomfortable. Gujarat-based pre-seed founders get a dedicated rail through the iCreate Angel Fund.